Poulton Stuart sold KPTI
March 1, 2024 · Form 4 insider transaction
Poulton Stuart sold 6,155 shares of Karyopharm Therapeutics Inc. at $1.20 per share, a transaction worth $7.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,155
Price
$1.20
Total value
$7.4K
InsiderPoulton Stuart
RoleOfficer
SecurityCommon
Transaction codeS: Open-market sale
Transaction dateMarch 1, 2024
Filing dateMarch 4, 2024
Shares owned after329,511
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of performance-based restricted stock units. The sale does not represent a discretionary trade by the reporting person.